VULNERABILITY NETWORK Canadian Trademark Information

On Wednesday, December 7, 2022, a canadian trademark registration was filed for VULNERABILITY NETWORK by Zephyr AI, Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 2263841. The current status of this trademark filing is Filing date accorded. The VULNERABILITY NETWORK trademark is filed in the description of Providing scientific consultancy services in the field of healthcare, medicine, genetics, oncology, biology, biotechnology and pharmaceuticals; analysis of healthcare, medical, genetic, scientific, biologic, clinical and oncologic data for scientific research purposes; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, biology, and pharmaceuticals; providing medical and scientific research information in the fields of genetics, oncology, biology, and pharmaceuticals; drug discovery services; healthcare, medical, and scientific services, namely, providing scientific information via databases in the fields of genetic, oncology, and biology for inputting, collecting, analyzing and managing data for treatment and diagnostic purposes; providing scientific, medical and clinical research and consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methods; medical and scientific research and consulting, namely, designing and supporting clinical trials for others; research and development services in the creation of databases and collections of information and data on biologicals for research purposes; providing genetic reference databases being collections of gene sequences for research purposes; disease modeling for research purposes; services using machine-learning algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer and other diseases; biomarker rankings; research and development of pharmaceutical preparations and medicines; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; medical and scientific research in the field of cancer treatment and diagnosis; genetic mapping for scientific purposes. , Genetic mapping for medical purposes; healthcare and medical services, namely, analyzing genetic, oncological, and biological data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies. .